Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to 18.41%.

  • Bio-Techne's EBIT Margin rose 24400.0% to 18.41% in Q4 2025 from the same period last year, while for Dec 2025 it was 9.62%, marking a year-over-year decrease of 71200.0%. This contributed to the annual value of 8.38% for FY2025, which is 94500.0% down from last year.
  • Bio-Techne's EBIT Margin amounted to 18.41% in Q4 2025, which was up 24400.0% from 16.63% recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's EBIT Margin ranged from a high of 2815.85% in Q3 2022 and a low of 7.53% during Q2 2025
  • Moreover, its 5-year median value for EBIT Margin was 22.62% (2021), whereas its average is 160.08%.
  • As far as peak fluctuations go, Bio-Techne's EBIT Margin surged by 27913200bps in 2022, and later plummeted by -27956800bps in 2023.
  • Bio-Techne's EBIT Margin (Quarter) stood at 23.15% in 2021, then increased by 8bps to 25.0% in 2022, then plummeted by -44bps to 13.94% in 2023, then rose by 15bps to 15.96% in 2024, then increased by 15bps to 18.41% in 2025.
  • Its last three reported values are 18.41% in Q4 2025, 16.63% for Q3 2025, and 7.53% during Q2 2025.